Sindh Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.90 M
- Company Age 36 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.30 M
- Satisfied Charges ₹ 2.95 M
- Revenue Growth 7.17%
- Profit Growth 34.18%
- Ebitda 31.40%
- Net Worth 272.37%
- Total Assets -5.29%
About Sindh Pharma
Sindh Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 April 1988 and has a history of 36 years and nine months. Its registered office is in Meerut, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.90 M.
The company currently has active open charges totaling ₹1.30 M. The company has closed loans amounting to ₹2.95 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Bhatija, Deepak Bhatija, Sunita Bhatija, and Four other members serve as directors at the Company.
Company Details
-
Location
Meerut, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85111UP1988PTC009515
-
Company No.
009515
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Apr 1988
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Sindh Pharma?
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Bhatija
|
Director | 07-Apr-1988 | Current |
|
Deepak Bhatija
|
Director | 07-Apr-1988 | Current |
|
Sunita Bhatija
|
Director | 16-May-2007 | Current |
|
Kiran Bhatija
|
Director | 07-Apr-1988 | Current |
|
Ankit Bhatija
|
Director | 28-Oct-2009 | Current |
|
Aman Bhatija
|
Director | 28-Oct-2009 | Current |
Financial Performance of Sindh Pharma.
Sindh Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.17% increase. The company also saw a substantial improvement in profitability, with a 34.18% increase in profit. The company's net worth Soared by an impressive increase of 272.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sindh Pharma?
In 2023, Sindh Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Wafture Healthcare Private LimitedSanjay Bhatija is a mutual person
-
Panchsheel Pharmaceuticals Private LimitedSanjay Bhatija, Deepak Bhatija and 5 more are mutual person
-
Biota Medicia Private Limited
Sanjay Bhatija, Sunita Bhatija and 2 more are mutual person
Charges (Loans)
₹1.30 M
₹2.95 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2021 | Hdfc Bank Limited | ₹1.30 M | Open |
| 31 Mar 2014 | Kotak Mahindra Prime Limited | ₹1.00 M | Satisfied |
| 23 Dec 2011 | Uco Bank | ₹0.65 M | Satisfied |
| 21 Jul 2009 | Bank Of Baroda | ₹1.30 M | Satisfied |
How Many Employees Work at Sindh Pharma?
Unlock and access historical data on people associated with Sindh Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sindh Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sindh Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
